EGFR and neoplasm: Recently, liquid biopsy approaches started to exploit the interplay of EGFR and EVs in delivering proteins, RNAs, and DNAs via blood/plasma of EGFR-dependent tumour patients to evaluate their possible roles and applications as candidate biomarkers in diagnosing and monitoring tumour progression and therapy efficacy.